Effects of lead time, length bias, and false-negative assurance on screening for breast cancer

Estimates of lead time and length bias i

Estimates of lead time and length bias in a breast cancer screening program

✍ Michael Shwartz 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 831 KB

Assume that the benefit of screening for breast cancer with a combination of mammography and a clinical examination is measured by comparing the five-year survival rate of women detected by screening to the five-year survival rate of women who surface clinically with breast cancer, e.g., to the surv